STudy of Atropine to Reduce (STAR) Myopia Progression in Children: 24‑Month Results of a Randomized, Double‑Masked, Vehicle‑Controlled Trial of Atropine Sulfate 0.01% and 0.03%

Korenfeld M.; Hurcikova M.; Tatsuoka K.; Cheetham J.; Kacerik M.; on behalf of the STAR Study Investigators

2026
Ophthalmol Ther

View publication

Therapeutic Area

Back of the eye (BOTE)
Categories

Clinical development

Affiliations

Comprehensive Eye Care, Ltd, Washington, MO, USA; Department of Ophthalmology, Nemocnica Penta Hospitals, Trebisov, Slovakia; Data Science, Santen Inc., Emeryville, CA, USA; Pediatric Ophthalmology Department, National Institute of Children’s Diseases, Bratislava, Slovakia; Sydnexis Clinical Consultant, Laguna Niguel, CA, 92677, USA; Department of Ophthalmology, Faculty Hospital, Trencin, Slovakia.

Related Publications

Cost-Effectiveness Analysis of Low-Dose Atropine Eye Drops (0.01%) for the Treatment of Myopia in Children: A United Kingdom Perspective

Shi-van Wielink K., Dahlmann-Noor A., Li J., de Milliano T.W.L., Ernst F., Croci F., Sharma Y., Punekar Y.

Two-year prospective natural history study of EYS-associated retinitis pigmentosa using adaptive optics: the KEYS study

Masakazu H., Akiko M., Midori Y., Elena G.-S., Shohei K., Satoshi Y., Yuki T., Masanao T., Shuhei K., Yasuhiko H., Yasuo K., Kiyoko G.

Prospective natural history and clinical biomarkers of EYS-associated retinopathy in the KEYS study

Taniguchi M, Togashi Y, Yokota S, Hiraoka M, Kitahata S, Nakamura N, Yamamoto M, Mandai M, Gocho K, Toshimori M, Hirami Y, Gomi F, Kurimoto Y, Maeda A.

View all Back of the eye (BOTE) publications